Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$16.9M Sell
182,500
-47,000
-20% -$4.29M 0.65% 31
2025
Q1
$20.1M Sell
229,500
-52,000
-18% -$5.11M 0.81% 32
2024
Q4
$26.1M Sell
281,500
-30,500
-10% -$2.94M 0.96% 32
2024
Q3
$29.4M Sell
312,000
-60,883
-16% -$5.11M 1.04% 25
2024
Q2
$27.6M Sell
372,883
-119,617
-24% -$9.54M 0.99% 28
2024
Q1
$42.5M Sell
492,500
-277,200
-36% -$21.2M 1.31% 25
2023
Q4
$53M Sell
769,700
-154,800
-17% -$9.34M 1.74% 21
2023
Q3
$51M Buy
+924,500
New +$52.5M 1.82% 21

Other funds holding CRH

Martin Currie's CRH Position: Q2 2025 in Review

Martin Currie reduced its CRH (CRH) stake by 20% in Q2 2025, selling an estimated $4.29M and leaving 182,500 shares worth $16.9M. The position accounts for 0.65% of the portfolio, ranked #31.

Martin Currie first reported a position in CRH in Q3 2023 and has held it in 8 quarters since. The position peaked at $53M in Q4 2023. 869 funds tracked by Wall St. Rank hold CRH as of Q2 2025.

  • Martin Currie held 182,500 shares of CRH worth $16.9M as of Q2 2025.
  • Martin Currie sold 47,000 CRH shares in Q2 2025, an estimated $4.29M.
  • CRH made up 0.65% of Martin Currie's portfolio in Q2 2025, its #31 holding.
  • Martin Currie first reported a position in CRH in Q3 2023 and has held it in 8 quarters since.
  • Martin Currie's CRH position peaked at $53M in Q4 2023.
  • 869 funds tracked by Wall St. Rank held CRH as of Q2 2025.

Based on Martin Currie's 13F filing for Q2 2025, filed 12 Aug 2025.